Related Experiment Video
Updated: Oct 9, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
[Drug-induced and toxic myopathies]
M Coquet1, B Bannwarth, D Henin
1Service d'anatomie pathologique et de neuropathologie, groupe hospitalier Pellegrin 33076 Bordeaux. michelle.coquet@chu.bordeaux.fr
Abstract:
A large number of drugs and toxins may induce myopathic changes in several ways, they are probably more common than realized. The clinical and pathological features depend on the causative agent and on individual susceptibility to a given compound. Based on their pathologic mechanisms, there are 6 main categories of toxic myopathies: necrotizing myopathy mainly due to lipid-lowering drugs (fibrates and statines); vacuolar myopathy, usually associated with antimalarial agents; inflammatory myopathy induced by thiol derivatives; mitochondrial myopathy; steroid myopathy, and hypokaliemic myopathy. Toxic myopathies are usually reversible after discontinuation of the offending agent. Their prompt recognition may reduce their damaging effects or prevent a fatal outcome. Muscle biopsy can be very useful for the diagnosis of toxic myopathies.
Insights
Toxic myopathies, induced by various drugs and toxins, are common and present diverse pathological mechanisms. Early diagnosis and agent discontinuation are crucial for reversibility and preventing severe outcomes.
Area of Science:
- Neurology
- Toxicology
- Pathology
Context:
- Drugs and toxins are frequently implicated in causing myopathic changes.
- The prevalence of toxic myopathies may be underestimated in clinical practice.
Purpose:
- To categorize the main types of toxic myopathies based on their pathological mechanisms.
- To highlight the importance of recognizing and diagnosing drug-induced myopathies.
Summary:
- Six main categories of toxic myopathies are identified: necrotizing, vacuolar, inflammatory, mitochondrial, steroid, and hypokalemic.
- Clinical and pathological features vary depending on the causative agent and individual susceptibility.
- Muscle biopsy is a valuable diagnostic tool for toxic myopathies.
Impact:
- Prompt identification and cessation of the offending agent can lead to reversible myopathic changes.
- Timely diagnosis can mitigate damaging effects and prevent potentially fatal outcomes associated with toxic myopathies.
Related Concept Videos
Drug Toxicity: Dose-Dependent Reactions
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Drug Toxicity: Overview
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Allergic Reactions
